A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Robaxisal Warnings, Precautions, Pregnancy, Nursing, Abuse - Methocarbamol and Aspirin
Robaxisal Warnings, Precautions, Pregnancy, Nursing, Abuse - Methocarbamol and Aspirin
WARNINGS
Since methocarbamol may possess a general central nervous system depressant
effect, patients receiving Robaxisal should be cautioned about combined effects
with alcohol and other CNS depressants.
PRECAUTIONS
Products containing aspirin should be administered with caution to patients
with gastritis or peptic ulceration, or those receiving hypoprothrombinemic
anticoagulants.
Methocarbamol may cause a color interference in certain screening tests for
5-hydroxyindoleacetic acid (5-HIAA) and vanillylmandelic acid (VMA).
PREGNANCY
Safe use of Robaxisal has not been established with regard to possible adverse
effects upon fetal development. Therefore, Robaxisal should not be used in women
who are or may become pregnant and particularly during early pregnancy unless
in the judgment of the physician the potential benefits outweigh the possible
hazards.
NURSING MOTHERS
It is not known whether methocarbamol is secreted in human milk; however, aspirin
does appear in human milk in moderate amounts. It can produce a bleeding tendency
either by interfering with the function of the infant's platelets or by decreasing
the amount of prothrombin in the blood. The risk is minimal if the mother takes
the aspirin just after nursing and if the infant has an adequate store of vitamin
K. As a general rule, nursing should not be undertaken while a patient is on
a drug.
PEDIATRIC USE
Safety and effectiveness in children 12 years of age and below have not been
established.
USE IN ACTIVITIES REQUIRING MENTAL ALERTNESS
Robaxisal may rarely cause drowsiness. Until the patient's response has been
determined, he should be cautioned against the operation of motor vehicles or
dangerous machinery.
top
